The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACELRX PHARMACEUTICAL-NEW | COM NEW | 00444T209 | 557,840 | 758,966 | SH | SOLE | 758,966 | 0 | 0 | ||
ASCENDIS PHARMA A/S ADR | SPONSORED ADR | 04351P101 | 2,115,960 | 16,800 | SH | SOLE | 16,800 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 8,668,477 | 1,128,708 | SH | SOLE | 1,128,708 | 0 | 0 | ||
CELLECTAR BIOSCIENCES-NEW | COM NEW | 15117F807 | 5,555,673 | 2,005,658 | SH | SOLE | 769,495 | 0 | 0 | ||
COMPASS PATHWAYS PLC ADR | SPONSORED ADS | 20451W101 | 6,986,875 | 798,500 | SH | SOLE | 798,500 | 0 | 0 | ||
DELCATH SYSTEMS, INC. | COM NEW | 24661P807 | 4,321,524 | 1,038,828 | SH | SOLE | 638,828 | 0 | 0 | ||
ENVVENO MEDICAL CORP | COM | 29415J106 | 1,604,148 | 312,091 | SH | SOLE | 312,091 | 0 | 0 | ||
FORTRESS BIOTECH INC-NEW | COM NEW | 34960Q307 | 1,829,469 | 607,797 | SH | SOLE | 607,797 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 422,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
INSPIREMD INC-NEW | COM | 45779A846 | 2,599,795 | 925,194 | SH | SOLE | 925,194 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS | COM | 483497103 | 3,675,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
LYRA THERAPEUTICS INC | COM | 55234L105 | 9,896,893 | 1,888,720 | SH | SOLE | 1,888,720 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS | COM | 558868105 | 5,784,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
MEDIWOUND LTD-NEW | SHS NEW | M68830112 | 6,170,658 | 606,751 | SH | SOLE | 606,751 | 0 | 0 | ||
MERRIMACK PHARMACEUT-NEW | COM NEW | 590328209 | 804,600 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
MYOMO INC-NEW | COM NEW | 62857J201 | 9,618,749 | 1,919,910 | SH | SOLE | 1,919,910 | 0 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 6,302,398 | 4,885,580 | SH | SOLE | 4,885,580 | 0 | 0 | ||
PROFOUND MEDICAL CORP-NEW | COM NEW | 74319B502 | 4,527,997 | 533,333 | SH | SOLE | 533,333 | 0 | 0 | ||
REVIVA PHARMACEUTICALS | COM | 76152G100 | 1,010,945 | 196,300 | SH | SOLE | 196,300 | 0 | 0 | ||
SAREPTA THEREAPEUTICS INC | COM | 803607100 | 5,535,082 | 57,400 | SH | SOLE | 57,400 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 4,648,129 | 1,586,392 | SH | SOLE | 1,586,392 | 0 | 0 | ||
TONIX PHARMA HLDG CRP-NEW | COM NEW | 890260854 | 363,063 | 900,900 | SH | SOLE | 900,900 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 2,495,650 | 1,862,425 | SH | SOLE | 1,862,425 | 0 | 0 | ||
VERONA PHARMA PLC SPN/ADR | SPONSORED ADS | 925050106 | 4,970,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
VERU INC | COM | 92536C103 | 2,880,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 7,848,031 | 360,332 | SH | SOLE | 360,332 | 0 | 0 | ||
XERIS BIOPHARMA HLDGS INC | COM | 98422E103 | 8,327,660 | 3,543,685 | SH | SOLE | 3,543,685 | 0 | 0 | ||
INVESCO QQQ TR | UNIT SER 1 | 46090E953 | 602,000 | 900,000 | SH | Put | SOLE | 900,000 | 0 | 0 | |
SAREPTA THERAPEUTICS INC | PUT | 803607950 | 832,300 | 57,400 | SH | Put | SOLE | 57,400 | 0 | 0 | |
SPDR SER TR | S&P BIOTECH | 78464A870 | 465,000 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 |